A multicenter prospective observational study on the use of type and screen method versus conventional type and crossmatch policy for pre-transfusion testing in the Indian population Cover

.blurhash-client-img { display: none !important; }

A multicenter prospective observational study on the use of type and screen method versus conventional type and crossmatch policy for pre-transfusion testing in the Indian population

Immunohematology

Volume 38 (2022): Issue 3 (September 2022)

By: A. Mathur, A. Jindal, A.K. Tiwari, D. Bhuyan, L. Jagannathan, R.B. Sawant, S. Basu, M. Reddy and S.S. Datta

Paid access

|Sep 2022

Authors

A. Mathur

Rotary TTK Blood Center, Bangalore Medical Services Trust, Bengaluru, India

A. Jindal

Transfusion Medicine, SPS Hospitals Ludhiana, Punjab, India

A.K. Tiwari

Medanta-The Medicity Hospital, Gurgaon, India

D. Bhuyan

Transfusion Medicine, Apollo Hospitals, Guwahati, India

L. Jagannathan

Rotary TTK Blood Center, Bangalore Medical Services Trust, Bengaluru, India

R.B. Sawant

Transfusion Medicine, Kokilaben Dhirubhai Ambani Hospital, Mumbai, India

S. Basu

Transfusion Medicine, Tata Medical Center, Kolkata, India

M. Reddy

Transfusion Medicine, Tata Medical Center, Kolkata, India

S.S. Datta

suvro.datta@gmail.com

Transfusion Medicine, Tata Medical Center, Kolkata, India

DOI: https://doi.org/10.21307/immunohematology-2022-050 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X

Journal RSS Feed

Language: English

Page range: 100 - 105

Published on: Sep 22, 2022

Published by: American National Red Cross

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

pre-transfusion testing,

type and screen,

type and crossmatch,

red blood cell transfusion,

alloimmunization

Related subjects:

Clinical medicine,

Laboratory medicine

© 2022 A. Mathur, A. Jindal, A.K. Tiwari, D. Bhuyan, L. Jagannathan, R.B. Sawant, S. Basu, M. Reddy, S.S. Datta, published by American National Red Cross
This work is licensed under the Creative Commons License.

Previous article Volume 38 (2022): Issue 3 (September 2022)Next article